Marketing-authorisation holder · United States
Sb Pharmco
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AVANDAMET1GM; 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1GM; 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 500MG; 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons* · Tablet | Metformin, Rosiglitazone | United States | Not marketed | 2002 |
| AVANDARYL1MG; 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2MG; 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2MG; 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 4MG; 4MG **Fe · Tablet | Glimepiride, Rosiglitazone | United States | Not marketed | 2005 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 2 | 2 | 0 | CompaniesAll medicines |